A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

A groundbreaking research conducted in France has unveiled compelling evidence linking caffeine consumption to reduced Alzheimer's risk.

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.

‘What’s the issue?’: Perak MB says Chinese tourists waving their national flag not an offence, cops to determine if they were Malaysians or otherwise The most beautiful brides from the movies 20 very angry-looking cars Former star footballer Abdelaziz Barrada dies at 35 years of age 4-day Deepavali weekend for Hindu civil servants Putin wants peace in Ukraine Revisiting the mistake Trump made that put into question his capability to govern Pahang Sultan's son, Tengku Muhammad marries Tengku Natasya

Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.